12.2 AAA Screening, Growth Rates & Rupture Risk

Screening and diagnostic examinations answer different questions

An abdominal aortic aneurysm (AAA) is generally defined as an abdominal aortic diameter of at least 3.0 cm. Screening seeks an unsuspected aneurysm in an appropriate asymptomatic population. Diagnostic evaluation addresses symptoms, a pulsatile mass, known disease, or another clinical concern. Do not use a screening eligibility rule to deny urgent evaluation of a symptomatic patient.

The USPSTF recommends one-time ultrasound screening for men aged 65–75 who have ever smoked; this is a Grade B recommendation. It recommends selective screening for men in that age group who have never smoked, considering individual risk. Recommendations for women differ by smoking and family history: routine screening is discouraged in women without those risks, while evidence is insufficient for women aged 65–75 who have ever smoked or have a family history. Other societies use different risk-based recommendations. Attribute the rule to its source rather than combining all policies into one universal age cutoff.

Measure before deciding that an aneurysm has grown

Measure the maximum outer-wall diameter in a plane perpendicular to the vessel axis, using the laboratory's consistent protocol. Include mural thrombus in the total aneurysm diameter. Oblique views of a tortuous aorta can overestimate size, while measuring only the patent lumen underestimates it. Document the maximum diameter and location relative to the renal arteries and iliac bifurcation as accessible.

Compare the same measurement convention and planes with prior imaging. A few millimeters of difference can reflect technique or modality rather than true growth. Review the images, not only the reported number, when a new measurement would alter management. If ultrasound cannot adequately define the aneurysm, additional imaging may be needed.

Surveillance: know which guideline is being used

The 2022 ACC/AHA aortic disease guideline recommends the following ultrasound intervals for asymptomatic AAA surveillance:

SVS guidance also uses three-year follow-up for 3.0–3.9 cm, annual follow-up for 4.0–4.9 cm, and six-month follow-up for 5.0–5.4 cm. Note the sex-specific difference in the ACC/AHA framework. Intervals may be shortened for symptoms, rapid change, concerning morphology, or a treating clinician's plan. Neither source supports describing annual, six-month, and three-month follow-up as the universal standard for those three size bands.

Referral and repair considerations

For an unruptured AAA, the ACC/AHA guideline recommends repair at a maximum diameter of at least 5.5 cm in men or 5.0 cm in women. These recommendations operate within a clinical assessment of operative risk, anatomy, life expectancy, and patient preferences. The sonographer reports the findings and communicates concerns; diameter alone is not an order to perform a specific procedure.

Symptoms attributable to an aneurysm, saccular morphology, or rapid expansion can alter management below the usual diameter threshold. Growth of at least 0.5 cm in six months is a reason for prompt specialist assessment and may support repair. Confirm comparability of the measurements before labeling rapid expansion. An unexplained change in a poor acoustic window should prompt further evaluation rather than a confidently assigned growth rate.

Worked surveillance cases

A 68-year-old man has an asymptomatic 3.6 cm AAA measured consistently with a previous study. Under the ACC/AHA size framework, routine surveillance is every three years, unless clinical factors justify another interval. Calling annual imaging universally mandatory would misstate that guideline.

A 70-year-old woman has an asymptomatic 4.7 cm AAA. The same framework recommends six-month surveillance because women reach the more frequent interval at 4.5 cm. A 4.7 cm AAA in a man would generally fall in the annual group. The source and sex matter; a generic “4–5 cm” rule loses information.

Rupture and symptomatic aneurysm

Rupture may cause sudden abdominal, back, or flank pain, hypotension or syncope, and a pulsatile mass. The complete classic triad may be absent. Do not wait for every feature before escalating a concerning presentation. A contained retroperitoneal rupture can temporarily preserve blood pressure; apparent stability is not reassurance.

Ultrasound can identify an aneurysm, but cannot reliably exclude rupture or characterize every retroperitoneal hemorrhage. Stop routine surveillance and activate urgent clinical assessment when symptoms suggest rupture. The treating team chooses definitive imaging or intervention based on stability. Do not delay emergency care to finish a perfect series of caliper images.

Morphology and differential diagnoses

Fusiform aneurysms enlarge the circumference; saccular lesions are more focal and require careful assessment of cause. An infected aneurysm may be irregular or saccular with inflammatory changes; the clinical context and additional imaging are essential. An inflammatory AAA can have a periaortic soft-tissue mantle and may entrap ureters, causing hydronephrosis. Evaluate visible renal collecting systems when appropriate and communicate the concern.

An aortic dissection may show an intimal flap and separate channels, but ultrasound may not define its full extent. Atherosclerotic plaque, mural thrombus, and artifact can mimic a flap. Use multiple planes and Doppler without assuming a single linear echo is diagnostic. Report what is seen and what remains outside the examination's capability.

Rupture risk rises with diameter but also depends on sex, growth, symptoms, morphology, and other factors. Avoid assigning a precise annual risk from an unsourced table. Consistent measurements, appropriate surveillance context, and timely communication are more useful than a falsely exact prediction for an individual patient.

USPSTF AAA screening, 2022 ACC/AHA aortic guideline, and SVS AAA recommendations — checked October 18, 2026.